Iovance Biotherapeutics Inc. Common Stock vs ONEOK Inc. Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.36 (market cap $5.85B), while ONEOK Inc. Common Stock trades at $90.5 (market cap $55.51B). The key difference: ONEOK Inc. Common Stock is far larger — about 9.5× Iovance Biotherapeutics Inc. Common Stock's market cap, and ONEOK Inc. Common Stock pays a 4.86% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and ONEOK Inc. Common Stock for 0 Days on average.
| IOVA | OKE | |
|---|---|---|
Market Cap | $5.85B | $55.51B |
Volume | 14,517,176 | 3,116,209 |
Sector | Health | Energy |
52-Week High | $14.82 | $97.51 |
52-Week Low | $1.81 | $64.31 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.78B | $88.37B |
Dividend Yield | — | 4.86% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →ONEOK operates energy infrastructure for natural gas, natural gas liquids, and crude oil. Its assets include pipelines, processing facilities, storage, and related services.
Read more on OKE →